| 5-FU | 5-Fluorouracil |
| ADCC | Antibody-dependent cell cytotoxicity |
| BM | Bone marrow |
| BME | Basement membrane extract |
| CAF | Cancer-associated fibroblasts |
| CAR | Chimeric antigen receptor |
| CEA | Carcinoembryonic antigen |
| CCL2 | C-C motif chemokine ligand 2 |
| CSF1R | Colony stimulating factor 1 receptor |
| CTL | Cytotoxic T lymphocytes |
| CXCL12 | C-X-C motif chemokine ligand 12 |
| CXCR4 | C-X-C chemokine receptor type 4 |
| DC | Dendritic cells |
| EC | Endothelial cells |
| ECM | Extracellular matrix |
| EGFR | Epidermal growth factor receptor |
| EMT | Epithelial to mesenchymal transition |
| FAP | Fibroblast-activation protein |
| FGF-2 | Fibroblast growth factor-2 |
| G-CSF | Granulocyte colony stimulating factor |
| HER2 | Human epidermal growth factor receptor 2 |
| HGF | Hepatocyte growth factor |
| HUVEC | Human umbilical vein endothelial cells |
| ICAM-1 | Intercellular adhesion molecule 1 |
| IFN-γ | Interferon- γ |
| IL-6 | Interleukin-6 |
| LOX | Lysyl oxidase |
| LPS | Lipopolysaccharide |
| MDSC | Myeloid-derived suppressor cells |
| MHC | Major histocompatibility complex |
| MMP | Matrix metalloproteinases |
| MSC | Mesenchymal stromal cells |
| M-CSF | Macrophage-colony stimulating factor |
| NK | Natural Killer cells |
| PBMC | Peripheral blood mononuclear cells |
| PEG | Poly(ethylene) glycol |
| PD-1 | Programmed cell death protein 1 |
| PD-L1 | Programmed death ligand 1 |
| PDGF | Platelet-derived growth factor |
| PMA | Phorbol-12-myristate-13-acetate |
| ROS | Reactive oxygen species |
| SMC | Smooth muscle cells |
| TAM | Tumour-associated macrophages |
| TGF-β | Transforming growth factor β |
| TIMP-1 | Tissue inhibitor of metalloproteinases 1 |
| TME | Tumour microenvironment |
| TNF-α | Tumour necrosis factor α |
| Treg | Regulatory T cells |
| VEGF | Vascular endothelial growth factor |
| α-SMA | α Smooth muscle actin |